CYCN
Companies
NASDAQ
Cyclerion Therapeutics Inc.
Health Care
$3.00
-$0.22 (-6.96%)
Price Chart
Overview
About CYCN
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
Market Cap
$6.4M
Volume
48.7K
Avg. Volume
43.9K
P/E Ratio
-2.3206108
Dividend Yield
0.00%
Employees
18.0
Company Information
Latest News for CYCN
Risk & Correlation Analysis
Market Correlation
1.25
Moderate Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CYCN shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$6.4M
Volume48.7K
P/E Ratio-2.32
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 12, 2023Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025